Showing results (2431-2440 of 2,814) with videos related to

Sort By:
Pageof 282
British Journal of Cancer|May 14, 2009
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonismB Cambien, B F Karimdjee, P Richard-Fiardo, et al.
Cancer|April 12, 2023
Dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF-mutant solid tumorsMeghan J Mooradian, James M Cleary, Anita Giobbie-Hurder, et al.
European Journal of Cancer (Oxford, England : 1990)|October 18, 2021
Immune checkpoint inhibitors for cancer and venous thromboembolic eventsJingyi Gong, Zsofia D Drobni, Raza M Alvi, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|November 8, 2021
Scout - sarcoidosis outcomes taskforce. A systematic review of outcomes to inform the development of a core outcome set for pulmonary sarcoidosisNicola L Harman, Sarah L Gorst, Paula R Williamson, et al.
Clinical and Vaccine Immunology : CVI|September 22, 2006
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trialJulie E Martin, Nancy J Sullivan, Mary E Enama, et al.
Hepatology (Baltimore, Md.)|October 31, 2009
Generation of functional human hepatic endoderm from human induced pluripotent stem cellsGareth J Sullivan, David C Hay, In-Hyun Park, et al.
Cancer|August 18, 2016
Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodiesAlain P Algazi, Katy K Tsai, Alexander N Shoushtari, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|February 15, 2023
Identifying a core outcome set for pulmonary sarcoidosis research - the Foundation for Sarcoidosis Research - Sarcoidosis Clinical OUtcomes Taskforce (SCOUT)Nicola L Harman, Sarah L Gorst, Paula R Williamson, et al.
Genome Medicine|November 17, 2020
PathoSPOT genomic epidemiology reveals under-the-radar nosocomial outbreaksAna Berbel Caban, Theodore R Pak, Ajay Obla, et al.
Pageof 282